Data mining for Pembrolizumab treatment response

This module identifies potential immunotherapy biomarkers by analyzing differences in RNA expression or tumor-infiltrating immune cell enrichment between responders and non-responders to Pembrolizumab treatment.


Data mining is focused on the association of Pembrolizumab response with RNA expression and tumor-infiltrating cell data

1) Browse genes and tumor-infiltrating cells associated with Pembrolizumab response, or directly plot the association between a gene expression levels and Pembrolizumab response

2) List of genes significantly associated with Pembrolizumab response

3) Pembrolizumab response in patients with low vs. high ERCC8 expression

4) Differential ERCC8 expression between responders and non-responders